1: Nho K, Horgusluoglu E, Kim S, Risacher SL, Kim D, Foroud T, Aisen PS, Petersen
RC, Jack CR Jr, Shaw LM, Trojanowski JQ, Weiner MW, Green RC, Toga AW, Saykin AJ;
ADNI. Integration of bioinformatics and imaging informatics for identifying rare 
PSEN1 variants in Alzheimer's disease. BMC Med Genomics. 2016 Aug 12;9 Suppl
1:30. doi: 10.1186/s12920-016-0190-9. PubMed PMID: 27535542.


2: Gamberger D, Ženko B, Mitelpunkt A, Shachar N, Lavrač N. Clusters of male and 
female Alzheimer's disease patients in the Alzheimer's Disease Neuroimaging
Initiative (ADNI) database. Brain Inform. 2016 Mar 30;3(3):169-179. eCollection
2016 Sep. PubMed PMID: 27525218; PubMed Central PMCID: PMC4963443.


3: Baykara E, Gesierich B, Adam R, Tuladhar AM, Biesbroek JM, Koek HL, Ropele S, 
Jouvent E; Alzheimer's Disease Neuroimaging Initiative (ADNI), Chabriat H,
Ertl-Wagner B, Ewers M, Schmidt R, de Leeuw FE, Biessels GJ, Dichgans M, Duering 
M. A novel imaging marker for small vessel disease based on skeletonization of
white matter tracts and diffusion histograms. Ann Neurol. 2016 Aug 12. doi:
10.1002/ana.24758. [Epub ahead of print] PubMed PMID: 27518166.


4: Hor S, Moradi M. Learning in data-limited multimodal scenarios: Scandent
decision forests and tree-based features. Med Image Anal. 2016 Jul 29. pii:
S1361-8415(16)30129-3. doi: 10.1016/j.media.2016.07.012. [Epub ahead of print]
PubMed PMID: 27498016.


5: Anderson ED, Wahoske M, Huber M, Norton D, Li Z, Koscik RL, Umucu E, Johnson
SC, Jones J, Asthana S, Gleason CE; Alzheimer's Disease Neuroimaging Initiative. 
Cognitive variability-A marker for incident MCI and AD: An analysis for the
Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement (Amst). 2016 May
26;4:47-55. doi: 10.1016/j.dadm.2016.05.003. eCollection 2016. PubMed PMID:
27489880; PubMed Central PMCID: PMC4961828.


6: Kandel BM, Avants BB, Gee JC, McMillan CT, Erus G, Doshi J, Davatzikos C, Wolk
DA. White matter hyperintensities are more highly associated with
preclinical Alzheimer's disease than imaging and cognitive markers
of neurodegeneration. Alzheimers Dement (Amst). 2016 Apr 7;4:18-27. doi:
10.1016/j.dadm.2016.03.001. eCollection 2016. PubMed PMID: 27489875; PubMed
Central PMCID: PMC4950175.


7: Bhagwat N, Pipitone J, Winterburn JL, Guo T, Duerden EG, Voineskos AN, Lepage 
M, Miller SP, Pruessner JC, Chakravarty MM. Manual-Protocol Inspired Technique
for Improving Automated MR Image Segmentation during Label Fusion. Front
Neurosci. 2016 Jul 19;10:325. doi: 10.3389/fnins.2016.00325. eCollection 2016.
PubMed PMID: 27486386; PubMed Central PMCID: PMC4949270.


8: Ortiz A, Munilla J, Górriz JM, Ramírez J. Ensembles of Deep Learning
Architectures for the Early Diagnosis of the Alzheimer's Disease. Int J Neural
Syst. 2016 Apr 4:1650025. [Epub ahead of print] PubMed PMID: 27478060.


9: Bozoki AC, Zdanukiewicz M, Zhu D; Alzheimer's Disease Neuroimaging Initiative.
The effect of β-amyloid positivity on cerebral metabolism in cognitively normal
seniors. Alzheimers Dement. 2016 Jul 18. pii: S1552-5260(16)30015-2. doi:
10.1016/j.jalz.2016.06.003. [Epub ahead of print] PubMed PMID: 27445158.


10: Luo X, Jiaerken Y, Yu X, Huang P, Qiu T, Jia Y, Sun J, Zhou J, Zhang M;
Alzheimer’s Disease Neuroimaging Initiative (ADNI). Affect of APOE on information
processing speed in non-demented elderly population: a preliminary structural MRI
study. Brain Imaging Behav. 2016 Jul 21. [Epub ahead of print] PubMed PMID:
27444731.


11: Taylor AN, Kambeitz-Ilankovic L, Gesierich B, Simon-Vermot L, Franzmeier N,
Araque Caballero MÁ, Müller S, Hesheng L, Ertl-Wagner B, Bürger K, Weiner MW,
Dichgans M, Duering M, Ewers M; Alzheimer's Disease Neuroimaging Initiative
(ADNI). Tract-specific white matter hyperintensities disrupt neural network
function in Alzheimer's disease. Alzheimers Dement. 2016 Jul 15. pii:
S1552-5260(16)32660-7. doi: 10.1016/j.jalz.2016.06.2358. [Epub ahead of print]
PubMed PMID: 27432800.


12: Iglesias JE, Van Leemput K, Augustinack J, Insausti R, Fischl B, Reuter M;
Alzheimer's Disease Neuroimaging Initiative. Bayesian longitudinal segmentation
of hippocampal substructures in brain MRI using subject-specific atlases.
Neuroimage. 2016 Jul 15;141:542-555. doi: 10.1016/j.neuroimage.2016.07.020. [Epub
ahead of print] PubMed PMID: 27426838.


13: Löwe LC, Gaser C, Franke K; Alzheimer’s Disease Neuroimaging Initiative. The 
Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild
Cognitive Impairment, and Alzheimer's Disease. PLoS One. 2016 Jul
13;11(7):e0157514. doi: 10.1371/journal.pone.0157514. eCollection 2016. PubMed
PMID: 27410431; PubMed Central PMCID: PMC4943637.


14: Plocharski M, Østergaard LR; Alzheimer's Disease Neuroimaging Initiative.
Extraction of sulcal medial surface and classification of Alzheimer's disease
using sulcal features. Comput Methods Programs Biomed. 2016 Sep;133:35-44. doi:
10.1016/j.cmpb.2016.05.009. Epub 2016 May 25. PubMed PMID: 27393798.


15: Li W, Risacher SL, Huang E, Saykin AJ; Alzheimer's Disease Neuroimaging
Initiative. Type 2 diabetes mellitus is associated with brain atrophy and
hypometabolism in the ADNI cohort. Neurology. 2016 Aug 9;87(6):595-600. doi:
10.1212/WNL.0000000000002950. Epub 2016 Jul 6. PubMed PMID: 27385744.


16: Guerrero R, Schmidt-Richberg A, Ledig C, Tong T, Wolz R, Rueckert D;
Alzheimer's Disease Neuroimaging Initiative (ADNI). Instantiated mixed effects
modeling of Alzheimer's disease markers. Neuroimage. 2016 Jul 2. pii:
S1053-8119(16)30298-1. doi: 10.1016/j.neuroimage.2016.06.049. [Epub ahead of
print] PubMed PMID: 27381077.


17: Martinez-Murcia FJ, Górriz JM, Ramírez J, Ortiz A. A Structural
Parametrization of the Brain Using Hidden Markov Models-Based Paths in
Alzheimer's Disease. Int J Neural Syst. 2016 Mar 29:1650024. [Epub ahead of
print] PubMed PMID: 27354189.


18: Takahashi R, Ishii K, Yokoyama K. Validation of a New Imaging Technique Using
the Glucose Metabolism to Amyloid Deposition Ratio in the Diagnosis of
Alzheimer's Disease. Curr Alzheimer Res. 2016 Jun 20. [Epub ahead of print]
PubMed PMID: 27334941.


19: Platero C, Tobar MC. A fast approach for hippocampal segmentation from T1-MRI
for predicting progression in Alzheimer's disease from elderly controls. J
Neurosci Methods. 2016 Sep 1;270:61-75. doi: 10.1016/j.jneumeth.2016.06.013. Epub
2016 Jun 17. PubMed PMID: 27328371.


20: Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-Pérez JM, Evans AC;
Alzheimer’s Disease Neuroimaging Initiative. Early role of vascular dysregulation
on late-onset Alzheimer's disease based on multifactorial data-driven analysis.
Nat Commun. 2016 Jun 21;7:11934. doi: 10.1038/ncomms11934. PubMed PMID: 27327500;
PubMed Central PMCID: PMC4919512.


21: Caminiti SP, Tettamanti M, Sala A, Presotto L, Iannaccone S, Cappa SF,
Magnani G, Perani D; Alzheimer’s Disease Neuroimaging Initiative (ADNI).
Metabolic connectomics targeting brain pathology in dementia with Lewy bodies. J 
Cereb Blood Flow Metab. 2016 Jun 15. pii: 0271678X16654497. [Epub ahead of print]
PubMed PMID: 27306756.


22: Adeli E, Shi F, An L, Wee CY, Wu G, Wang T, Shen D. Joint feature-sample
selection and robust diagnosis of Parkinson's disease from MRI data. Neuroimage. 
2016 Jun 10;141:206-219. doi: 10.1016/j.neuroimage.2016.05.054. [Epub ahead of
print] PubMed PMID: 27296013.


23: Hao X, Yao X, Yan J, Risacher SL, Saykin AJ, Zhang D, Shen L; Alzheimer’s
Disease Neuroimaging Initiative. Identifying Multimodal Intermediate Phenotypes
Between Genetic Risk Factors and Disease Status in Alzheimer's Disease.
Neuroinformatics. 2016 Jun 9. [Epub ahead of print] PubMed PMID: 27277494.


24: Liu H, Zhou X, Jiang H, He H, Liu X; Alzheimer’s Disease Neuroimaging
Initiative. A semi-mechanism approach based on MRI and proteomics for prediction 
of conversion from mild cognitive impairment to Alzheimer's disease. Sci Rep.
2016 Jun 7;6:26712. doi: 10.1038/srep26712. PubMed PMID: 27273250; PubMed Central
PMCID: PMC4896009.


25: Ma J, Zhang W, Tan L, Wang HF, Wan Y, Sun FR, Tan CC, Yu JT, Tan L,
Alzheimer's Disease Neuroimaging Initiative. MS4A6A genotypes are associated with
the atrophy rates of Alzheimer's disease related brain structures. Oncotarget.
2016 May 23. doi: 10.18632/oncotarget.9563. [Epub ahead of print] PubMed PMID:
27244883.


26: Zhang P, Wu G, Gao Y, Yap PT, Shen D. A dynamic tree-based registration could
handle possible large deformations among MR brain images. Comput Med Imaging
Graph. 2016 Sep;52:1-7. doi: 10.1016/j.compmedimag.2016.04.005. Epub 2016 May 14.
PubMed PMID: 27235894; PubMed Central PMCID: PMC4930896.


27: Lim NS, Swanson CR, Cherng HR, Unger TL, Xie SX, Weintraub D, Marek K, Stern 
MB, Siderowf A; PARS Investigators; Alzheimer's Disease Neuroimaging Initiative, 
Trojanowski JQ, Chen-Plotkin AS. Plasma EGF and cognitive decline in Parkinson's 
disease and Alzheimer's disease. Ann Clin Transl Neurol. 2016 Mar 29;3(5):346-55.
doi: 10.1002/acn3.299. eCollection 2016 May. PubMed PMID: 27231704; PubMed
Central PMCID: PMC4863747.


28: Fotiadis P, van Rooden S, van der Grond J, Schultz A, Martinez-Ramirez S,
Auriel E, Reijmer Y, van Opstal AM, Ayres A, Schwab KM, Alzheimer's Disease
Neuroimaging Initiative Adni, Hedden T, Rosand J, Viswanathan A, Wermer M,
Terwindt GM, Sperling RA, Polimeni JR, Johnson KA, van Buchem MA, Greenberg SM,
Gurol ME. Cortical atrophy in patients with cerebral amyloid angiopathy: a
case-control study. Lancet Neurol. 2016 Jul;15(8):811-9. doi:
10.1016/S1474-4422(16)30030-8. Epub 2016 May 11. PubMed PMID: 27180034.


29: Pereira JB, Mijalkov M, Kakaei E, Mecocci P, Vellas B, Tsolaki M, Kłoszewska 
I, Soininen H, Spenger C, Lovestone S, Simmons A, Wahlund LO, Volpe G, Westman E;
AddNeuroMed consortium, for the Alzheimer's Disease Neuroimaging Initiative.
Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive
Impairment and Alzheimer's Disease. Cereb Cortex. 2016 Aug;26(8):3476-93. doi:
10.1093/cercor/bhw128. Epub 2016 May 13. PubMed PMID: 27178195; PubMed Central
PMCID: PMC4961019.


30: Yin RH, Li J, Tan L, Wang HF, Tan MS, Yu WJ, Tan CC, Yu JT, Tan L;
Alzheimer's Disease Neuroimaging Initiative. Impact of SORL1 genetic variations
on MRI markers in non-demented elders. Oncotarget. 2016 May 11. doi:
10.18632/oncotarget.9300. [Epub ahead of print] PubMed PMID: 27177090.


31: Xu W, Wang HF, Tan L, Tan MS, Tan CC, Zhu XC, Miao D, Yu WJ, Jiang T, Tan L, 
Yu JT; Alzheimer’s Disease Neuroimaging Initiative Group. The impact of PICALM
genetic variations on reserve capacity of posterior cingulate in AD continuum.
Sci Rep. 2016 Apr 27;6:24480. doi: 10.1038/srep24480. PubMed PMID: 27117083;
PubMed Central PMCID: PMC4846810.


32: Hyun JW, Li Y, Huang C, Styner M, Lin W, Zhu H; Alzheimer's Disease
Neuroimaging Initiative. STGP: Spatio-temporal Gaussian process models for
longitudinal neuroimaging data. Neuroimage. 2016 Jul 1;134:550-62. doi:
10.1016/j.neuroimage.2016.04.023. Epub 2016 Apr 19. PubMed PMID: 27103140; PubMed
Central PMCID: PMC4912881.


33: Konukoglu E, Coutu JP, Salat DH, Fischl B; Alzheimer's Disease Neuroimaging
Initiative (ADNI). Multivariate statistical analysis of diffusion imaging
parameters using partial least squares: Application to white matter variations in
Alzheimer's disease. Neuroimage. 2016 Jul 1;134:573-86. doi:
10.1016/j.neuroimage.2016.04.038. Epub 2016 Apr 19. PubMed PMID: 27103138; PubMed
Central PMCID: PMC4912936.


34: Schmidt-Richberg A, Ledig C, Guerrero R, Molina-Abril H, Frangi A, Rueckert
D; Alzheimer’s Disease Neuroimaging Initiative. Learning Biomarker Models for
Progression Estimation of Alzheimer's Disease. PLoS One. 2016 Apr
20;11(4):e0153040. doi: 10.1371/journal.pone.0153040. eCollection 2016. PubMed
PMID: 27096739; PubMed Central PMCID: PMC4838309.


35: Jie B, Liu M, Liu J, Zhang D, Shen D. Temporally-Constrained Group Sparse
Learning for Longitudinal Data Analysis in Alzheimer's Disease. IEEE Trans Biomed
Eng. 2016 Apr 13. [Epub ahead of print] PubMed PMID: 27093313.


36: Risacher SL, McDonald BC, Tallman EF, West JD, Farlow MR, Unverzagt FW, Gao
S, Boustani M, Crane PK, Petersen RC, Jack CR Jr, Jagust WJ, Aisen PS, Weiner MW,
Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative. Association Between
Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy
in Cognitively Normal Older Adults. JAMA Neurol. 2016 Jun 1;73(6):721-32. doi:
10.1001/jamaneurol.2016.0580. PubMed PMID: 27088965.


37: Loring DW, Goldstein FC, Chen C, Drane DL, Lah JJ, Zhao L, Larrabee GJ;
Alzheimer's Disease Neuroimaging Initiative. False-Positive Error Rates for
Reliable Digit Span and Auditory Verbal Learning Test Performance Validity
Measures in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease. Arch 
Clin Neuropsychol. 2016 Jun;31(4):313-31. doi: 10.1093/arclin/acw014. Epub 2016
Apr 15. PubMed PMID: 27084732; PubMed Central PMCID: PMC4876935.


38: Teipel S, Grothe MJ; Alzheimer’s Disease Neuroimaging Initiative. Association
Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and
Prodromal and Dementia Stages of Alzheimer's Disease. J Alzheimers Dis. 2016 Apr 
12;52(4):1443-51. doi: 10.3233/JAD-151100. PubMed PMID: 27079707.


39: Kim J, Zhang Y, Pan W; Alzheimer's Disease Neuroimaging Initiative. Powerful 
and Adaptive Testing for Multi-trait and Multi-SNP Associations with GWAS and
Sequencing Data. Genetics. 2016 Jun;203(2):715-31. doi:
10.1534/genetics.115.186502. Epub 2016 Apr 13. PubMed PMID: 27075728; PubMed
Central PMCID: PMC4896189.


40: Li B, Shi J, Gutman BA, Baxter LC, Thompson PM, Caselli RJ, Wang Y;
Alzheimer’s Disease Neuroimaging Initiative. Influence of APOE Genotype on
Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study. PLoS One.
2016 Apr 11;11(4):e0152901. doi: 10.1371/journal.pone.0152901. eCollection 2016. 
PubMed PMID: 27065111; PubMed Central PMCID: PMC4827849.


41: Wang ZX, Wang HF, Tan L, Liu J, Wan Y, Sun FR, Tan MS, Tan CC, Jiang T, Tan
L, Yu JT; Alzheimer’s Disease Neuroimaging Initiative. Effects of HLA-DRB1/DQB1
Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and
Alzheimer's Disease Cohorts. Mol Neurobiol. 2016 Apr 7. [Epub ahead of print]
PubMed PMID: 27056075.


42: Lorenzi M, Simpson IJ, Mendelson AF, Vos SB, Cardoso MJ, Modat M, Schott JM, 
Ourselin S. Multimodal Image Analysis in Alzheimer's Disease via Statistical
Modelling of Non-local Intensity Correlations. Sci Rep. 2016 Apr 11;6:22161. doi:
10.1038/srep22161. PubMed PMID: 27064442; PubMed Central PMCID: PMC4827392.


43: Luo X, Zhu L, Zhu H. Single-index varying coefficient model for functional
responses. Biometrics. 2016 Apr 8. doi: 10.1111/biom.12526. [Epub ahead of print]
PubMed PMID: 27061414.


44: Wang ZX, Wan Y, Tan L, Liu J, Wang HF, Sun FR, Tan MS, Tan CC, Jiang T, Tan
L, Yu JT; Alzheimer’s Disease Neuroimaging Initiative. Genetic Association of HLA
Gene Variants with MRI Brain Structure in Alzheimer's Disease. Mol Neurobiol.
2016 Apr 7. [Epub ahead of print] PubMed PMID: 27056077.


45: Tong T, Gao Q, Guerrero R, Ledig C, Chen L, Rueckert D. A Novel Grading
Biomarker for the Prediction of Conversion from Mild Cognitive Impairment to
Alzheimer's Disease. IEEE Trans Biomed Eng. 2016 Apr 1. [Epub ahead of print]
PubMed PMID: 27046891.


46: Bangen KJ, Clark AL, Werhane M, Edmonds EC, Nation DA, Evangelista N, Libon
DJ, Bondi MW, Delano-Wood L; Alzheimer’s Disease Neuroimaging Initiative.
Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive
Impairment Subtypes and Interaction with APOE ɛ4 Genotype. J Alzheimers Dis. 2016
Mar 29;52(3):849-61. doi: 10.3233/JAD-150900. PubMed PMID: 27031472; PubMed
Central PMCID: PMC4884141.


47: Högenauer M, Brendel M, Delker A, Därr S, Weiss M, Bartenstein P, Rominger A,
Alzheimer's Disease Neuroimaging Initiative. Impact of MRI-based Segmentation
Artifacts on Amyloid- and FDG-PET Quantitation. Curr Alzheimer Res.
2016;13(5):597-607. PubMed PMID: 27025775.


48: Roostaei T, Nazeri A, Felsky D, De Jager PL, Schneider JA, Pollock BG,
Bennett DA, Voineskos AN; Alzheimer’s Disease Neuroimaging Initiative (ADNI).
Genome-wide interaction study of brain beta-amyloid burden and cognitive
impairment in Alzheimer's disease. Mol Psychiatry. 2016 Mar 29. doi:
10.1038/mp.2016.35. [Epub ahead of print] PubMed PMID: 27021820.


49: Li W, Risacher SL, McAllister TW, Saykin AJ. Traumatic brain injury and age
at onset of cognitive impairment in older adults. J Neurol. 2016
Jul;263(7):1280-5. doi: 10.1007/s00415-016-8093-4. Epub 2016 Mar 23. Erratum in: 
J Neurol. 2016 Jul;263(7):1286. PubMed PMID: 27007484.


50: Zhao QF, Wan Y, Wang HF, Sun FR, Hao XK, Tan MS, Tan CC, Zhang DQ, Tan L, Yu 
JT; Alzheimer’s Disease Neuroimaging Initiative. ABCA7 Genotypes Confer
Alzheimer's Disease Risk by Modulating Amyloid-β Pathology. J Alzheimers Dis.
2016 Mar 21;52(2):693-703. doi: 10.3233/JAD-151005. PubMed PMID: 27003212.


51: Wang HF, Wan Y, Hao XK, Cao L, Zhu XC, Jiang T, Tan MS, Tan L, Zhang DQ, Tan 
L, Yu JT; Disease Neuroimaging Initiative Alzheimer’s. Bridging Integrator 1
(BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal
Degeneration. J Alzheimers Dis. 2016 Mar 15;52(1):179-90. doi:
10.3233/JAD-150972. PubMed PMID: 27003210.


52: Wang ZX, Wang HF, Tan L, Sun FR, Tan MS, Tan CC, Jiang T, Tan L, Yu JT;
Alzheimer’s Disease Neuroimaging Initiative. HLA-A2 Alleles Mediate Alzheimer's
Disease by Altering Hippocampal Volume. Mol Neurobiol. 2016 Mar 15. [Epub ahead
of print] PubMed PMID: 26979752.


53: Brendel M, Reinisch V, Kalinowski E, Levin J, Delker A, Därr S, Pogarell O,
Förster S, Bartenstein P, Rominger A, Alzheimer's Disease Neuroimaging
Initiative. Hypometabolism in Brain of Cognitively Normal Patients with
Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects.
Curr Alzheimer Res. 2016;13(5):475-86. PubMed PMID: 26971944.


54: Krashenyi I, Ramírez J, Popov A, Górriz JM, The Alzheimer's Disease
Neuroimaging Initiative. Fuzzy Computer-Aided Alzheimer's Disease Diagnosis Based
on MRI Data. Curr Alzheimer Res. 2016;13(5):545-56. PubMed PMID: 26971942.


55: Landau SM, Horng A, Fero A, Jagust WJ; Alzheimer's Disease Neuroimaging
Initiative. Amyloid negativity in patients with clinically diagnosed Alzheimer
disease and MCI. Neurology. 2016 Apr 12;86(15):1377-85. doi:
10.1212/WNL.0000000000002576. Epub 2016 Mar 11. PubMed PMID: 26968515; PubMed
Central PMCID: PMC4831042.


56: Gomar JJ, Conejero-Goldberg C, Davies P, Goldberg TE; Alzheimer’s Disease
Neuroimaging Initiative. Anti-Correlated Cerebrospinal Fluid Biomarker
Trajectories in Preclinical Alzheimer's Disease. J Alzheimers Dis.
2016;51(4):1085-97. doi: 10.3233/JAD-150937. PubMed PMID: 26967213.


57: Ueki M, Tamiya G; Alzheimer's Disease Neuroimaging Initiative.
Smooth-Threshold Multivariate Genetic Prediction with Unbiased Model Selection.
Genet Epidemiol. 2016 Apr;40(3):233-43. doi: 10.1002/gepi.21958. Epub 2016 Mar 6.
PubMed PMID: 26947266.


58: Li Z, Suk HI, Shen D, Li L. Sparse Multi-Response Tensor Regression for
Alzheimer's Disease Study With Multivariate Clinical Assessments. IEEE Trans Med 
Imaging. 2016 Aug;35(8):1927-36. doi: 10.1109/TMI.2016.2538289. Epub 2016 Mar 4. 
PubMed PMID: 26960221.


59: Liu S, Cai W, Pujol S, Kikinis R, Feng DD; Alzheimer's Disease Neuroimaging
Initiative. Cross-View Neuroimage Pattern Analysis in Alzheimer's Disease
Staging. Front Aging Neurosci. 2016 Feb 23;8:23. doi: 10.3389/fnagi.2016.00023.
eCollection 2016. PubMed PMID: 26941639; PubMed Central PMCID: PMC4763344.


60: Palmqvist S, Mattsson N, Hansson O; Alzheimer’s Disease Neuroimaging
Initiative. Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation 
earlier than positron emission tomography. Brain. 2016 Apr;139(Pt 4):1226-36.
doi: 10.1093/brain/aww015. Epub 2016 Mar 2. PubMed PMID: 26936941; PubMed Central
PMCID: PMC4806222.


61: Varol E, Sotiras A, Davatzikos C; Alzheimer's Disease Neuroimaging
Initiative. HYDRA: Revealing heterogeneity of imaging and genetic patterns
through a multiple max-margin discriminative analysis framework. Neuroimage. 2016
Feb 23. pii: S1053-8119(16)00150-6. doi: 10.1016/j.neuroimage.2016.02.041. [Epub 
ahead of print] PubMed PMID: 26923371.


62: Fortin JP, Sweeney EM, Muschelli J, Crainiceanu CM, Shinohara RT; Alzheimer's
Disease Neuroimaging Initiative. Removing inter-subject technical variability in 
magnetic resonance imaging studies. Neuroimage. 2016 May 15;132:198-212. doi:
10.1016/j.neuroimage.2016.02.036. Epub 2016 Feb 23. PubMed PMID: 26923370.


63: Xu L, Wu X, Li R, Chen K, Long Z, Zhang J, Guo X, Yao L; Alzheimer’s Disease 
Neuroimaging Initiative. Prediction of Progressive Mild Cognitive Impairment by
Multi-Modal Neuroimaging Biomarkers. J Alzheimers Dis. 2016;51(4):1045-56. doi:
10.3233/JAD-151010. PubMed PMID: 26923024.


64: Andriuta D, Moullart V, Schraen S, Devendeville A, Meyer ME, Godefroy O;
Alzheimer’s Disease Neuroimaging. What are the Most Frequently Impaired Markers
of Neurodegeneration in ADNI Subjects? J Alzheimers Dis. 2016;51(3):793-800. doi:
10.3233/JAD-150829. PubMed PMID: 26923012.


65: Suppa P, Hampel H, Kepp T, Lange C, Spies L, Fiebach JB, Dubois B, Buchert R;
Alzheimer’s Disease Neuroimaging Initiative. Performance of Hippocampus Volumetry
with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects
with Amnestic Mild Cognitive Impairment. J Alzheimers Dis. 2016;51(3):867-73.
doi: 10.3233/JAD-150804. PubMed PMID: 26923010.


66: White MT, Shaw LM, Xie SX; Alzheimer’s Disease Neuroimaging Initiative;
National Alzheimer’s Coordinating Center. Evaluation of Cerebrospinal Fluid Assay
Variability in Alzheimer's Disease. J Alzheimers Dis. 2016;51(2):463-70. doi:
10.3233/JAD-151045. PubMed PMID: 26890778; PubMed Central PMCID: PMC4930357.


67: Hu WT, Watts KD, Tailor P, Nguyen TP, Howell JC, Lee RC, Seyfried NT, Gearing
M, Hales CM, Levey AI, Lah JJ, Lee EK; Alzheimer’s Disease Neuro-Imaging
Initiative. CSF complement 3 and factor H are staging biomarkers in Alzheimer's
disease. Acta Neuropathol Commun. 2016 Feb 17;4:14. doi:
10.1186/s40478-016-0277-8. PubMed PMID: 26887322; PubMed Central PMCID:
PMC4758165.


68: Koran ME, Wagener M, Hohman TJ; Alzheimer’s Neuroimaging Initiative. Sex
differences in the association between AD biomarkers and cognitive decline. Brain
Imaging Behav. 2016 Feb 3. [Epub ahead of print] PubMed PMID: 26843008; PubMed
Central PMCID: PMC4972701.


69: Wang HF, Tan L, Cao L, Zhu XC, Jiang T, Tan MS, Liu Y, Wang C, Tsai RM, Jia
JP, Yu JT; Alzheimer’s Disease Neuroimaging Initiative. Application of the IWG-2 
Diagnostic Criteria for Alzheimer's Disease to the ADNI. J Alzheimers Dis.
2016;51(1):227-36. doi: 10.3233/JAD-150824. PubMed PMID: 26836176.


70: Wang WY, Liu Y, Wang HF, Tan L, Sun FR, Tan MS, Tan CC, Jiang T, Tan L, Yu
JT; Alzheimer’s Disease Neuroimaging Initiative. Impacts of CD33 Genetic
Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in
Normal Aging and Mild Cognitive Impairment. Mol Neurobiol. 2016 Jan 23. [Epub
ahead of print] PubMed PMID: 26803496.


71: Song A, Yan J, Kim S, Risacher SL, Wong AK, Saykin AJ, Shen L, Greene CS;
Alzheimer’s Disease Neuroimaging Initiative. Network-based analysis of genetic
variants associated with hippocampal volume in Alzheimer's disease: a study of
ADNI cohorts. BioData Min. 2016 Jan 19;9:3. doi: 10.1186/s13040-016-0082-8.
eCollection 2016. PubMed PMID: 26788126; PubMed Central PMCID: PMC4717572.


72: Hao X, Yan J, Yao X, Risacher SL, Saykin AJ, Zhang D, Shen L; ADNI.
DIAGNOSIS-GUIDED METHOD FOR IDENTIFYING MULTI-MODALITY NEUROIMAGING BIOMARKERS
ASSOCIATED WITH GENETIC RISK FACTORS IN ALZHEIMER'S DISEASE. Pac Symp Biocomput. 
2016;21:108-19. PubMed PMID: 26776178; PubMed Central PMCID: PMC4719777.


73: Whelan CD, Hibar DP, van Velzen LS, Zannas AS, Carrillo-Roa T, McMahon K,
Prasad G, Kelly S, Faskowitz J, deZubiracay G, Iglesias JE, van Erp TG, Frodl T, 
Martin NG, Wright MJ, Jahanshad N, Schmaal L, Sämann PG, Thompson PM; Alzheimer's
Disease Neuroimaging Initiative. Heritability and reliability of automatically
segmented human hippocampal formation subregions. Neuroimage. 2016
Mar;128:125-37. doi: 10.1016/j.neuroimage.2015.12.039. Epub 2015 Dec 30. PubMed
PMID: 26747746; PubMed Central PMCID: PMC4883013.


74: Liu M, Zhang D, Shen D. Relationship Induced Multi-Template Learning for
Diagnosis of Alzheimer's Disease and Mild Cognitive Impairment. IEEE Trans Med
Imaging. 2016 Jun;35(6):1463-74. doi: 10.1109/TMI.2016.2515021. Epub 2016 Jan 5. 
PubMed PMID: 26742127.


75: Ighodaro ET, Abner EL, Fardo DW, Lin AL, Katsumata Y, Schmitt FA, Kryscio RJ,
Jicha GA, Neltner JH, Monsell SE, Kukull WA, Moser DK, Appiah F, Bachstetter AD, 
Van Eldik LJ; Alzheimer's Disease Neuroimaging Initiative (ADNI), Nelson PT. Risk
factors and global cognitive status related to brain arteriolosclerosis in
elderly individuals. J Cereb Blood Flow Metab. 2016 Jan 6. pii: 0271678X15621574.
[Epub ahead of print] PubMed PMID: 26738751.


76: Li JQ, Wang HF, Zhu XC, Sun FR, Tan MS, Tan CC, Jiang T, Tan L, Yu JT;
Alzheimer’s Disease Neuroimaging Initiative. GWAS-Linked Loci and Neuroimaging
Measures in Alzheimer's Disease. Mol Neurobiol. 2016 Jan 5. [Epub ahead of print]
PubMed PMID: 26732597.


77: Sørensen L, Igel C, Liv Hansen N, Osler M, Lauritzen M, Rostrup E, Nielsen M;
Alzheimer's Disease Neuroimaging Initiative and the Australian Imaging Biomarkers
and Lifestyle Flagship Study of Ageing. Early detection of Alzheimer's disease
using MRI hippocampal texture. Hum Brain Mapp. 2016 Mar;37(3):1148-61. doi:
10.1002/hbm.23091. Epub 2015 Dec 21. PubMed PMID: 26686837.


78: An H, Son SJ, Cho S, Cho EY, Choi B, Kim SY; Alzheimer's Disease Neuroimaging
Initiative. Large intracranial volume accelerates conversion to dementia in males
and APOE4 non-carriers with mild cognitive impairment. Int Psychogeriatr. 2016
May;28(5):769-78. doi: 10.1017/S104161021500229X. Epub 2015 Dec 17. PubMed PMID: 
26674540.


79: Trzepacz PT, Hochstetler H, Yu P, Castelluccio P, Witte MM, Dell'Agnello G,
Degenhardt EK; Alzheimer''s Disease Neuroimaging Initiative. Relationship of
Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's
Disease. Dement Geriatr Cogn Disord. 2016;41(1-2):68-79. doi: 10.1159/000441351. 
Epub 2015 Dec 2. PubMed PMID: 26625159.


80: Souza MB, Araújo GS, Costa IG, Oliveira JR; Alzheimer’s Disease Neuroimaging 
Initiative. Combined Genome-Wide CSF Aβ-42's Associations and Simple Network
Properties Highlight New Risk Factors for Alzheimer's Disease. J Mol Neurosci.
2016 Jan;58(1):120-8. doi: 10.1007/s12031-015-0667-6. Epub 2015 Nov 17. PubMed
PMID: 26576771.


81: Ferreira D, Cavallin L, Granberg T, Lindberg O, Aguilar C, Mecocci P, Vellas 
B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO,
Westman E; AddNeuroMed consortium and for the Alzheimer’s Disease Neuroimaging
Initiative*. Quantitative validation of a visual rating scale for frontal
atrophy: associations with clinical status, APOE e4, CSF biomarkers and
cognition. Eur Radiol. 2016 Aug;26(8):2597-610. doi: 10.1007/s00330-015-4101-9.
Epub 2015 Nov 11. PubMed PMID: 26560730.


82: Wu G, Kim M, Wang Q, Munsell BC, Shen D. Scalable High-Performance Image
Registration Framework by Unsupervised Deep Feature Representations Learning.
IEEE Trans Biomed Eng. 2016 Jul;63(7):1505-16. doi: 10.1109/TBME.2015.2496253.
Epub 2015 Nov 2. PubMed PMID: 26552069; PubMed Central PMCID: PMC4853306.


83: Hua X, Ching CR, Mezher A, Gutman BA, Hibar DP, Bhatt P, Leow AD, Jack CR Jr,
Bernstein MA, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging
Initiative. MRI-based brain atrophy rates in ADNI phase 2: acceleration and
enrichment considerations for clinical trials. Neurobiol Aging. 2016
Jan;37:26-37. doi: 10.1016/j.neurobiolaging.2015.09.018. Epub 2015 Oct 19. PubMed
PMID: 26545631; PubMed Central PMCID: PMC4827255.


84: Chincarini A, Sensi F, Rei L, Gemme G, Squarcia S, Longo R, Brun F, Tangaro
S, Bellotti R, Amoroso N, Bocchetta M, Redolfi A, Bosco P, Boccardi M, Frisoni
GB, Nobili F; Alzheimer's Disease Neuroimaging Initiative. Integrating
longitudinal information in hippocampal volume measurements for the early
detection of Alzheimer's disease. Neuroimage. 2016 Jan 15;125:834-47. doi:
10.1016/j.neuroimage.2015.10.065. Epub 2015 Oct 26. PubMed PMID: 26515904.


85: Ebbert MT, Boehme KL, Wadsworth ME, Staley LA; Alzheimer's Disease
Neuroimaging Initiative; Alzheimer's Disease Genetics Consortium, Mukherjee S,
Crane PK, Ridge PG, Kauwe JS. Interaction between variants in CLU and MS4A4E
modulates Alzheimer's disease risk. Alzheimers Dement. 2016 Feb;12(2):121-9. doi:
10.1016/j.jalz.2015.08.163. Epub 2015 Oct 9. PubMed PMID: 26449541; PubMed
Central PMCID: PMC4744542.


86: Liu Y, Tan L, Wang HF, Liu Y, Hao XK, Tan CC, Jiang T, Liu B, Zhang DQ, Yu
JT; Alzheimer’s Disease Neuroimaging Initiative. Multiple Effect of APOE Genotype
on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum. Mol 
Neurobiol. 2016 Sep;53(7):4539-47. doi: 10.1007/s12035-015-9388-7. Epub 2015 Aug 
23. PubMed PMID: 26298664.


87: Falkovskiy P, Brenner D, Feiweier T, Kannengiesser S, Maréchal B, Kober T,
Roche A, Thostenson K, Meuli R, Reyes D, Stoecker T, Bernstein MA, Thiran JP,
Krueger G. Comparison of accelerated T1-weighted whole-brain structural-imaging
protocols. Neuroimage. 2016 Jan 1;124(Pt A):157-67. doi:
10.1016/j.neuroimage.2015.08.026. Epub 2015 Aug 20. PubMed PMID: 26297848.


88: Giraud R, Ta VT, Papadakis N, Manjón JV, Collins DL, Coupé P; Alzheimer's
Disease Neuroimaging Initiative. An Optimized PatchMatch for multi-scale and
multi-feature label fusion. Neuroimage. 2016 Jan 1;124(Pt A):770-82. doi:
10.1016/j.neuroimage.2015.07.076. Epub 2015 Aug 2. PubMed PMID: 26244277.


89: Zhang DF, Li J, Wu H, Cui Y, Bi R, Zhou HJ, Wang HZ, Zhang C, Wang D;
Alzheimer's Disease Neuroimaging Initiative (ADNI), Kong QP, Li T, Fang Y, Jiang 
T, Yao YG. CFH Variants Affect Structural and Functional Brain Changes and
Genetic Risk of Alzheimer's Disease. Neuropsychopharmacology. 2016
Mar;41(4):1034-45. doi: 10.1038/npp.2015.232. Epub 2015 Aug 5. PubMed PMID:
26243271; PubMed Central PMCID: PMC4748428.


90: Wang C, Wang HF, Tan MS, Liu Y, Jiang T, Zhang DQ, Tan L, Yu JT; Alzheimer’s 
Disease Neuroimaging Initiative. Impact of Common Variations in PLD3 on
Neuroimaging Phenotypes in Non-demented Elders. Mol Neurobiol. 2016
Sep;53(7):4343-51. doi: 10.1007/s12035-015-9370-4. Epub 2015 Aug 1. PubMed PMID: 
26232066.


91: Ramirez J, McNeely AA, Scott CJ, Masellis M, Black SE; Alzheimer's Disease
Neuroimaging Initiative. White matter hyperintensity burden in elderly cohort
studies: The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging
Initiative, and Three-City Study. Alzheimers Dement. 2016 Feb;12(2):203-10. doi: 
10.1016/j.jalz.2015.06.1886. Epub 2015 Jul 21. PubMed PMID: 26208292.


92: Ni H, Zhou L, Ning X, Wang L; Alzheimer's Disease Neuroimaging Initiative
(ADNI). Exploring multifractal-based features for mild Alzheimer's disease
classification. Magn Reson Med. 2016 Jul;76(1):259-69. doi: 10.1002/mrm.25853.
Epub 2015 Jul 20. PubMed PMID: 26193379.


93: Suk HI, Lee SW, Shen D; Alzheimer’s Disease Neuroimaging Initiative. Deep
sparse multi-task learning for feature selection in Alzheimer's disease
diagnosis. Brain Struct Funct. 2016 Jun;221(5):2569-87. doi:
10.1007/s00429-015-1059-y. Epub 2015 May 21. PubMed PMID: 25993900; PubMed
Central PMCID: PMC4714963.